The immune system comprises organs, tissues, cells and molecules, which protect the body against pathogens.
Detailed description
The biological defense system can be separated into an innate and an adaptive part. The innate immune system developed early in the phylogeny of living things. The adaptive immune system adjusts to new or modified pathogens. Both parts collaborate closely. Moreover, the immune system can destroy abnormal or defective cells of the own body.
More about “Immune system”
Use of image only in connection with this press release.
Pathogenic strains of Salmonella inject effector proteins into the cells of the gastrointestinal tract to invade and multiply within them. The bacteria are usually ingested with contaminated food
Kidneys are the most transplanted organ in Germany. According to the German Organ Transplantation Foundation, a total of 1,514 kidneys were transplanted after post-mortem organ donation in 2023, out
An international research group led by scientists of the German Center for Infection Research (DZIF) at the Helmholtz Centre for Infection Research (HZI) has discovered a promising new drug candidate
Infections with the hepatitis E virus often go unnoticed because they cause no symptoms. However, in patients with weakened immune systems or pre-existing liver damage, and in pregnant women, the
Changes in diet and the environment constantly pose new challenges to the human metabolism. Different organs and tissues work together in complex interactions to keep the metabolism in balance. The
Organ transplant patients usually have to take immunosuppressive drugs for the rest of their lives to prevent their bodies from rejecting the organs. This therapy suppresses the physiological immune response to tumors and infections. The therapeutic goal for this patient group is to achieve an ...
Viruses are masters at disguise. When they are pushed too far by our immune system, they send new virus variants into play that are no longer recognized by immune cells. They escape our immune system
EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV)
